Some help is here – the RAUORA quit smoking study is currently underway in the Lakes District Health Board (DHB) region (including Rotorua, Taupo and Turangi). The study compares two similar medicines (Tabex and Champix) to see how good they are at helping people to quit smoking cigarettes.
The medicine ‘Tabex’ has been used for more than 50 years in Eastern Europe to help people quit smoking. Tabex contains cytisine, which is obtained from a plant called the Golden Rain. Cytisine is also found in several New Zealand plants, including the Kōwhai.
The best treatment available in New Zealand to help people quit smoking is a medicine called ‘Champix’, also known as varenicline. Varenicline is not obtained from a plant, but has been developed from cytisine.
The research team are looking for 2,140 Māori and whānau of Māori who smoke and are keen to quit, to join the study. People will be randomised (like the flip of a coin) to receive a prescription for 12 weeks of either Tabex or Champix, and will be followed up for six months. All medicine is provided free – no doctor visits, no pharmacy costs, everything is done over the phone.
Sound interesting? Want to know more?
- Call: 0800 367 644
- Text: ‘your name’ + ‘RAUORA’ to 4073
- Email: firstname.lastname@example.org
- Facebook: @RAUORAtrial
- Web: auora.nihi.auckland.ac.nz
RAUORA is a collaboration between the University of Auckland, Brunel University London, and Lakes DHB, with support from Tipu Ora. Dr Barry Smith (Te Rarawa and Ngati Kahu) from the Lakes DHB is one of the investigators on the study, and leads the RAUORA kaitiaki group. Other members include: Eru George (Pou Herenga, Māori Health Division, Lakes DHB), Ngaroma Mala Grant (Manager, Te Arawa Whanau Ora), Marita Ranclaud (Portfolio Manager, Mental Health and Addictions), and Yvonne Rogers (Smokefree Coordinator, Lakes DHB).